Ligand validation:1WMA

P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1WMA_P33_A_311	27%	55%	0.154	0.809	0.69	1.02	-	-	23	0	95%	0.5
3BHJ_P33_A_316	19%	44%	0.154	0.78	1.05	1.13	-	2	2	0	82%	0.8182
9J8F_P33_A_401	98%	75%	0.046	0.97	0.55	0.44	-	-	0	0	100%	1
6QF3_P33_A_406	94%	86%	0.074	0.973	0.48	0.24	-	-	0	0	100%	0.45
4KL9_P33_A_202	92%	56%	0.073	0.963	0.72	0.96	-	-	1	0	100%	0.5
7EHT_P33_A_514	83%	82%	0.092	0.949	0.36	0.44	-	-	0	0	100%	1
5L2V_P33_A_202	81%	60%	0.11	0.962	0.46	1.06	-	1	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.